comparemela.com

Latest Breaking News On - Drug and device safety - Page 6 : comparemela.com

Rare diseases: Visibility through art

More than 30 million people in Europe live with a rare disease. Their medical needs are far too often overlooked.

Christian deleuzeEuropean networksLuxembourg based australianRare disease paradoxAid and developmentDrug and device safetyHealth careRare diseasesResearch and developmentSociety and culture

Belgium in race to burn seized cocaine before gangs steal it back

The country’s drugs commissioner will present a plan to tackle drug-related crimes to Belgium’s National Security Council on Wednesday.

United statesZuhal demirVan wymerschJohan lippensKristian vanderwaerenNational security council onLatin americaNational security councilFriday belgianDrug and device safetyIllicit drugsThe netherlands

Campaigners sound conflict of interest alarm over MEP couple, missing pharma report

The romantic relationship between Pernille Weiss and Christian Ehler has raised questions about why an independent study was taken offline.

Alberto alemannoMeps weissPernille weissChristian ehlerShari hindsOlivier hoedemanAdvisory committeeEuropean people partyTransparency international hindsEuropean parliamentMember of the european parliamentEuropean peopleCorporate europe observatoryBig pharmaGood lobbyBusiness and competition

The mysterious case of the MEP lovers and the disappearing EU pharma report

A European Parliament study that centers on the delicate topic of incentives for drug companies was published, then pulled offline again, pending further queries from MEPs.

Christian ehlerPaolo pertilePernille weissMaria manuel leitTechnology christian creutzEu parliamentEuropean people partyEuropean parliamentEuropean peopleAid and developmentCertification and standardsDrug and device safetyDrug pricingHealth careMaria manuel leitão marquesPublic health

Biosimilar matters

Why we should stop devaluing biosimilar medicines at all costs.

United statesEuropean medicines agencyVoluntary schemeBranded medicines pricingFrench social security finance billAid and developmentBusiness and competitionClinical trialsCompetition antitrustDrug and device safetyFinance and bankingGenerics and biosimilarsHealth careRaw materialsSupply chainsUnited kingdom

vimarsana © 2020. All Rights Reserved.